CORCEPT THERAPEUTICS INC Diluted Shares Outstanding (Weighted Average)
CORCEPT THERAPEUTICS INC (CORT) reported Diluted Shares Outstanding (Weighted Average) of 118.39 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 118.39M shares, a 1.74% decline year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 104.44M shares, a 12.84% decline year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 120.00M shares, a 0.67% increase year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 119.44M shares, a 5.03% increase year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for fiscal 2025 was 119.99M shares, a 5.73% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for fiscal 2024 was 113.48M shares, a 1.56% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for fiscal 2023 was 111.74M shares, a 3.64% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, diluted for fiscal 2022 was 115.97M shares, a 7.94% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 118.39M shares 10-Q · filed 2026-07-29 | 116.37M shares 10-Q · filed 2026-07-29 | 114.28M shares derived: average of 3 quarters · filed 2026-07-29 | 115.57M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | 104.44M shares 10-Q · filed 2026-04-30 | 112.22M shares derived: average of 2 quarters · filed 2026-04-30 | 114.63M shares derived: average of 3 quarters · filed 2026-04-30 | 116.09M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | 120.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 119.72M shares derived: average of 2 quarters · filed 2026-02-24 | 119.98M shares derived: average of 3 quarters · filed 2026-07-29 | 119.99M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 119.44M shares 10-Q · filed 2025-11-04 | 119.96M shares derived: average of 2 quarters · filed 2026-07-29 | 119.98M shares 10-Q · filed 2025-11-04 | 119.74M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | 120.48M shares 10-Q · filed 2026-07-29 | 120.23M shares 10-Q · filed 2026-07-29 | 119.84M shares derived: average of 3 quarters · filed 2026-07-29 | 118.31M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | 119.82M shares 10-Q · filed 2026-04-30 | 119.51M shares derived: average of 2 quarters · filed 2026-04-30 | 117.58M shares derived: average of 3 quarters · filed 2026-04-30 | 116.00M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 119.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 116.47M shares derived: average of 2 quarters · filed 2026-02-24 | 114.72M shares derived: average of 3 quarters · filed 2026-02-24 | 113.48M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 113.72M shares 10-Q · filed 2025-11-04 | 112.48M shares derived: average of 2 quarters · filed 2025-11-04 | 111.57M shares 10-Q · filed 2025-11-04 | 111.42M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 111.24M shares 10-Q · filed 2025-07-31 | 110.55M shares 10-Q · filed 2025-07-31 | 110.66M shares derived: average of 3 quarters · filed 2026-02-24 | 110.77M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 109.92M shares 10-Q · filed 2025-05-05 | 110.36M shares derived: average of 2 quarters · filed 2026-02-24 | 110.61M shares derived: average of 3 quarters · filed 2026-02-24 | 110.35M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 110.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 110.95M shares derived: average of 2 quarters · filed 2026-02-24 | 110.50M shares derived: average of 3 quarters · filed 2026-02-24 | 111.74M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 111.10M shares 10-Q · filed 2024-10-30 | 110.34M shares derived: average of 2 quarters · filed 2024-10-30 | 112.05M shares 10-Q · filed 2024-10-30 | 113.13M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 109.59M shares 10-Q · filed 2024-07-29 | 112.49M shares 10-Q · filed 2024-07-29 | 113.81M shares derived: average of 3 quarters · filed 2025-02-26 | 114.51M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 115.42M shares 10-Q · filed 2024-05-01 | 115.92M shares derived: average of 2 quarters · filed 2025-02-26 | 116.15M shares derived: average of 3 quarters · filed 2025-02-26 | 115.96M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 116.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 116.52M shares derived: average of 2 quarters · filed 2025-02-26 | 116.14M shares derived: average of 3 quarters · filed 2025-02-26 | 115.97M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 116.62M shares 10-Q · filed 2023-11-01 | 116.01M shares derived: average of 2 quarters · filed 2023-11-01 | 115.82M shares 10-Q · filed 2023-11-01 | 117.35M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | 115.40M shares 10-Q · filed 2023-08-02 | 115.22M shares 10-Q · filed 2023-08-02 | 117.59M shares derived: average of 3 quarters · filed 2024-02-15 | 119.48M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | 115.04M shares 10-Q · filed 2023-05-03 | 118.69M shares derived: average of 2 quarters · filed 2024-02-15 | 120.84M shares derived: average of 3 quarters · filed 2024-02-15 | 122.30M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | 122.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 123.73M shares derived: average of 2 quarters · filed 2024-02-15 | 124.72M shares derived: average of 3 quarters · filed 2024-02-15 | 125.96M shares 10-K · filed 2024-02-15 |
| 2021-09-30 | 125.14M shares 10-Q · filed 2022-11-03 | 125.91M shares derived: average of 2 quarters · filed 2022-11-03 | 127.17M shares 10-Q · filed 2022-11-03 | 127.06M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | 126.68M shares 10-Q · filed 2022-08-04 | 128.20M shares 10-Q · filed 2022-08-04 | 127.70M shares derived: average of 3 quarters · filed 2023-02-28 | 126.89M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | 129.67M shares 10-Q · filed 2022-05-05 | 128.22M shares derived: average of 2 quarters · filed 2023-02-28 | 126.97M shares derived: average of 3 quarters · filed 2023-02-28 | 126.03M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 126.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 125.61M shares derived: average of 2 quarters · filed 2023-02-28 | 124.82M shares derived: average of 3 quarters · filed 2023-02-28 | 124.19M shares 10-K · filed 2023-02-28 |
| 2020-09-30 | 124.46M shares 10-Q · filed 2021-11-03 | 123.85M shares derived: average of 2 quarters · filed 2021-11-03 | 123.34M shares 10-Q · filed 2021-11-03 | 123.19M shares derived: average of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 123.23M shares 10-Q · filed 2021-07-29 | 122.76M shares 10-Q · filed 2021-07-29 | 122.76M shares derived: average of 3 quarters · filed 2022-02-15 | 122.51M shares derived: average of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 122.23M shares 10-Q · filed 2021-05-06 | 122.53M shares derived: average of 2 quarters · filed 2022-02-15 | 122.27M shares derived: average of 3 quarters · filed 2022-02-15 | 122.15M shares derived: average of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 122.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 122.30M shares derived: average of 2 quarters · filed 2022-02-15 | 122.13M shares derived: average of 3 quarters · filed 2022-02-15 | 122.57M shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 121.76M shares 10-Q · filed 2020-11-03 | 121.77M shares derived: average of 2 quarters · filed 2020-11-03 | 122.48M shares 10-Q · filed 2020-11-03 | 123.17M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | 121.78M shares 10-Q · filed 2020-08-04 | 122.83M shares 10-Q · filed 2020-08-04 | 123.64M shares derived: average of 3 quarters · filed 2021-02-23 | 124.27M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | 123.89M shares 10-Q · filed 2020-05-04 | 124.57M shares derived: average of 2 quarters · filed 2021-02-23 | 125.10M shares derived: average of 3 quarters · filed 2021-02-23 | 125.70M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | 125.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | 125.70M shares derived: average of 2 quarters · filed 2021-02-23 | 126.31M shares derived: average of 3 quarters · filed 2021-02-23 | 126.69M shares 10-K · filed 2021-02-23 |
| 2018-09-30 | 126.16M shares 10-Q · filed 2019-11-07 | 126.84M shares derived: average of 2 quarters · filed 2019-11-07 | 127.17M shares 10-Q · filed 2019-11-07 | 127.30M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | 127.52M shares 10-Q · filed 2019-08-01 | 127.61M shares 10-Q · filed 2019-08-01 | 127.69M shares derived: average of 3 quarters · filed 2020-02-24 | 127.18M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | 127.73M shares 10-Q · filed 2019-05-09 | 127.77M shares derived: average of 2 quarters · filed 2020-02-24 | 127.06M shares derived: average of 3 quarters · filed 2020-02-24 | 126.05M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | 127.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | 126.73M shares derived: average of 2 quarters · filed 2020-02-24 | 125.49M shares derived: average of 3 quarters · filed 2020-02-24 | 124.52M shares 10-K · filed 2020-02-24 |
| 2017-09-30 | 125.65M shares 10-Q · filed 2018-11-02 | 124.33M shares derived: average of 2 quarters · filed 2018-11-02 | 123.42M shares 10-Q · filed 2018-11-02 | 122.23M shares derived: average of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | 123.01M shares 10-Q · filed 2018-08-09 | 122.17M shares 10-Q · filed 2018-08-09 | 121.09M shares derived: average of 3 quarters · filed 2019-02-26 | 119.92M shares derived: average of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | 121.19M shares 10-Q · filed 2018-05-09 | 120.13M shares derived: average of 2 quarters · filed 2019-02-26 | 118.89M shares derived: average of 3 quarters · filed 2019-02-26 | 118.00M shares derived: average of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | 119.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 117.74M shares derived: average of 2 quarters · filed 2019-02-26 | 116.94M shares derived: average of 3 quarters · filed 2019-02-26 | 116.14M shares 10-K · filed 2019-02-26 |
| 2016-09-30 | 116.42M shares 10-Q · filed 2017-11-03 | 115.87M shares derived: average of 2 quarters · filed 2017-11-03 | 115.16M shares 10-Q · filed 2017-11-03 | 112.66M shares derived: average of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | 115.33M shares 10-Q · filed 2017-08-02 | 114.45M shares 10-Q · filed 2017-08-02 | 111.40M shares derived: average of 3 quarters · filed 2018-02-28 | 110.67M shares derived: average of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | 109.66M shares 10-Q · filed 2017-05-02 | 109.44M shares derived: average of 2 quarters · filed 2018-02-28 | 109.11M shares derived: average of 3 quarters · filed 2018-02-28 | 108.80M shares derived: average of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | 109.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 108.84M shares derived: average of 2 quarters · filed 2018-02-28 | 108.52M shares derived: average of 3 quarters · filed 2018-02-28 | 106.88M shares 10-K · filed 2018-02-28 |
| 2015-09-30 | 108.46M shares 10-Q · filed 2016-11-02 | 108.17M shares derived: average of 2 quarters · filed 2016-11-02 | 106.10M shares 10-Q · filed 2016-11-02 | |
| 2015-06-30 | 107.87M shares 10-Q · filed 2016-08-03 | 104.91M shares 10-Q · filed 2016-08-03 | ||
| 2014-12-31 | 100.98M shares 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |